Start Over

Smoking-Attributable mortality in Spain in 2016.

Authors :: Pérez-Ríos M
Schiaffino A
Montes A
Fernández E
López MJ
Martínez-Sánchez JM
Sureda X
Martínez C
Fu M
Continente XG
Carretero JL
Galán I
Source :: Archivos de bronconeumologia [Arch Bronconeumol] 2020 Sep; Vol. 56 (9), pp. 559-563. Date of Electronic Publication: 2020 Jul 18.
Publication Year :: 2020
Abstract: Introduction: Smoking-attributable mortality (SAM) is a valuable indicator that can be used to characterize the course and health burden of the smoking epidemic. The aim of this paper was to estimate SAM in Spain in 2016 in the population aged 35 and over, using the best available evidence.<br />Methods: A smoking prevalence-dependent analysis based on the estimation of population-attributable fractions was performed. Smoking prevalence (never, former, and current smokers) was calculated from a combination of the Spanish Health Survey (2016) and the European Health Survey (2014); the relative risk of death among current and former smokers was taken from the follow-up of various cohorts; and mortality rates were obtained from National Center for Statistics data. SAM estimates are presented globally, and by sex, age groups, and major disease categories: cancer, cardiometabolic diseases and respiratory diseases.<br />Results: In 2016, 56,124 deaths were attributed to tobacco consumption, 84% in men (47,000), and 50% in the population aged over 74 (27,795). Overall, 50% of SAM was due to cancer (28,281), 65% of which was lung cancer. One in 4 attributable deaths (13,849) occurred before the age of 65.<br />Conclusions: One in 7 deaths in Spain in 2016 were attributable to smoking. This estimation of SAM clearly highlights the great impact of smoking on mortality in Spain, mainly due to lung cancer and chronic obstructive pulmonary disease.<br /> (Copyright © 2020 SEPAR. Published by Elsevier España, S.L.U. All rights reserved.)